GB201520390D0 - Composition - Google Patents

Composition

Info

Publication number
GB201520390D0
GB201520390D0 GBGB1520390.4A GB201520390A GB201520390D0 GB 201520390 D0 GB201520390 D0 GB 201520390D0 GB 201520390 A GB201520390 A GB 201520390A GB 201520390 D0 GB201520390 D0 GB 201520390D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1520390.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GBGB1520390.4A priority Critical patent/GB201520390D0/en
Publication of GB201520390D0 publication Critical patent/GB201520390D0/en
Priority to SG11201803913RA priority patent/SG11201803913RA/en
Priority to CA3005775A priority patent/CA3005775A1/en
Priority to ES16801029T priority patent/ES2799516T3/es
Priority to BR112018009886A priority patent/BR112018009886A2/pt
Priority to MX2018006157A priority patent/MX2018006157A/es
Priority to PCT/GB2016/053600 priority patent/WO2017085502A1/en
Priority to KR1020187017271A priority patent/KR20180074797A/ko
Priority to US15/777,333 priority patent/US20180344726A1/en
Priority to CN201680067561.0A priority patent/CN108601747A/zh
Priority to EP16801029.6A priority patent/EP3377048B1/en
Priority to AU2016355113A priority patent/AU2016355113A1/en
Priority to JP2018526061A priority patent/JP2018534319A/ja
Priority to IL259457A priority patent/IL259457A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GBGB1520390.4A 2015-11-19 2015-11-19 Composition Ceased GB201520390D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1520390.4A GB201520390D0 (en) 2015-11-19 2015-11-19 Composition
JP2018526061A JP2018534319A (ja) 2015-11-19 2016-11-18 疼痛の治療のためのオピオイドアゴニスト及び非経皮的に送達されるオピオイドアンタゴニストのｎ−オキシド誘導体を含む乱用防止性の経皮的送達デバイス及び組成物
PCT/GB2016/053600 WO2017085502A1 (en) 2015-11-19 2016-11-18 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered n-oxide derivative of an opioid antagonist for the treatment of pain
US15/777,333 US20180344726A1 (en) 2015-11-19 2016-11-18 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered n-oxide derivative of an opioid antagonist for the treatment of pain
ES16801029T ES2799516T3 (es) 2015-11-19 2016-11-18 Dispositivos de administración transdérmica resistentes al abuso y composiciones que comprenden un agonista de opioides y un derivado N-óxido no administrado por vía transdérmica de un antagonista de opioide para el tratamiento del dolor
BR112018009886A BR112018009886A2 (pt) 2015-11-19 2016-11-18 composições e dispositivos de liberação transdérmica resistentes ao abuso compreendendo um agonista opioide e um derivado n-óxido de um antagonista opioide não liberado transdermicamente para o tratamento da dor
MX2018006157A MX2018006157A (es) 2015-11-19 2016-11-18 Dispositivos y composiciones de administracion transdermica resistentes al abuso que comprenden un agonista de opioide y un derivado de n-oxido administrado por la ruta no transdermica de un antagonista de opioide para el tratamiento del dolor.
SG11201803913RA SG11201803913RA (en) 2015-11-19 2016-11-18 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered n-oxide derivative of an opioid antagonist for the treatment of pain
KR1020187017271A KR20180074797A (ko) 2015-11-19 2016-11-18 통증 치료를 위한 오피오이드 작용제 및 오피오이드 길항제의 비-경피 전달된 n-옥시드 유도체를 포함하는 남용 방지 경피 전달 장치 및 조성물
CA3005775A CA3005775A1 (en) 2015-11-19 2016-11-18 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered n-oxide derivative of an opioid antagonist for the treatment of pain
CN201680067561.0A CN108601747A (zh) 2015-11-19 2016-11-18 用于治疗疼痛的防滥用的透皮递送装置和包含类阿片激动剂和不透皮递送的类阿片拮抗剂的n-氧化物衍生物的组合物
EP16801029.6A EP3377048B1 (en) 2015-11-19 2016-11-18 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered n-oxide derivative of an opioid antagonist for the treatment of pain
AU2016355113A AU2016355113A1 (en) 2015-11-19 2016-11-18 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered N-oxide derivative of an opioid antagonist for the treatment of pain
IL259457A IL259457A (en) 2015-11-19 2018-05-17 Abuse resistant transdermal delivery devices and compositions comprising an opioid agonist and a non-transdermally delivered n-oxide derivative of an opioid antagonist for the treatment of pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1520390.4A GB201520390D0 (en) 2015-11-19 2015-11-19 Composition

Publications (1)

Publication Number Publication Date
GB201520390D0 true GB201520390D0 (en) 2016-01-06

Family

ID=55133015

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1520390.4A Ceased GB201520390D0 (en) 2015-11-19 2015-11-19 Composition

Country Status (14)

Country Link
US (1) US20180344726A1 (enExample)
EP (1) EP3377048B1 (enExample)
JP (1) JP2018534319A (enExample)
KR (1) KR20180074797A (enExample)
CN (1) CN108601747A (enExample)
AU (1) AU2016355113A1 (enExample)
BR (1) BR112018009886A2 (enExample)
CA (1) CA3005775A1 (enExample)
ES (1) ES2799516T3 (enExample)
GB (1) GB201520390D0 (enExample)
IL (1) IL259457A (enExample)
MX (1) MX2018006157A (enExample)
SG (1) SG11201803913RA (enExample)
WO (1) WO2017085502A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081754A1 (en) * 2018-10-18 2020-04-23 Avior, Inc. Method and device of treating chronic kidney disease-associated pruritus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722928A (en) * 1985-12-02 1988-02-02 E. I. Du Pont De Nemours And Company N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
SI1299104T1 (sl) * 2000-02-08 2009-10-31 Euro Celtique Sa Oralne formulacije opioidnih agonistov, varne pred zlorabo
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
SI1513532T1 (sl) * 2002-06-10 2007-08-31 Euro Celtique Sa Sistemi za odstranjevanje priprav za transdermalno oddajanje za preprečevanje zlorabe učinkovin, ki jih vsebujejo
ES2324719T3 (es) * 2004-02-23 2009-08-13 Euro-Celtique S.A. Dispositivo de administracion transdermica de opioides con resistencia al abuso.
AU2007329590A1 (en) * 2006-11-22 2008-06-12 Progenics Pharmaceuticals, Inc. N-oxides of 4,5-epoxy-morphinanium analogs
WO2009067275A1 (en) * 2007-11-21 2009-05-28 Progenics Pharmaceuticals, Inc N-oxides of 4,5-epoxy-morphinanium analogs
US20090246265A1 (en) * 2008-03-26 2009-10-01 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
US8829020B2 (en) * 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
ES2592277T3 (es) * 2010-04-02 2016-11-29 Buzzz Pharmaceuticals Limited Formulaciones transdérmicas disuasorias del abuso de agonistas y agonistas-antagonistas opiáceos

Also Published As

Publication number Publication date
EP3377048A1 (en) 2018-09-26
KR20180074797A (ko) 2018-07-03
CN108601747A (zh) 2018-09-28
WO2017085502A1 (en) 2017-05-26
IL259457A (en) 2018-07-31
EP3377048B1 (en) 2020-04-22
ES2799516T3 (es) 2020-12-18
MX2018006157A (es) 2019-04-04
CA3005775A1 (en) 2017-05-26
AU2016355113A1 (en) 2018-05-24
US20180344726A1 (en) 2018-12-06
SG11201803913RA (en) 2018-06-28
JP2018534319A (ja) 2018-11-22
BR112018009886A2 (pt) 2018-11-13

Similar Documents

Publication Publication Date Title
GB201512030D0 (en) Composition
GB201505527D0 (en) Composition
GB201521507D0 (en) Composition
GB201506827D0 (en) Composition
SG11201705867VA (en) Composition
GB201506825D0 (en) Composition
GB201506829D0 (en) Composition
GB201506830D0 (en) Composition
PT3344702T (pt) Composição
GB2545773B (en) Composition
GB201504665D0 (en) Composition
GB201522603D0 (en) Composition
GB201515639D0 (en) Composition
GB201504307D0 (en) Composition
GB201522681D0 (en) Composition
GB201519327D0 (en) Composition
GB201518348D0 (en) Composition
GB201514585D0 (en) Composition
GB201506828D0 (en) Composition
GB201505520D0 (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
GB2537648B (en) Composition
GB201521384D0 (en) Composition
GB201515734D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)